Actively Recruiting
Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema
Led by Jessa Hospital · Updated on 2023-02-28
104
Participants Needed
2
Research Sites
362 weeks
Total Duration
On this page
Sponsors
J
Jessa Hospital
Lead Sponsor
H
Hasselt University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Up to one out of five patients with breast cancer will develop lymphedema in the upper extremity after cancer treatment. Patients with breast cancer-related lymphedema (BCRL) suffer from pain, heaviness, tightness, and a decreased range of motion. Photobiomodulation therapy (PBMT) is a non-invasive therapy based on the application of visible and/or near-infrared light produced by a laser diode or a light-emitting diode. The scientifically proven biologic effects of PBM are improved wound healing, and a reduction in pain, inflammation, and oedema. Therefore, the aim of this study is to evaluate the effectiveness of PBMT on the management of BCRL.
CONDITIONS
Official Title
Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with breast cancer
- Underwent ipsilateral lumpectomy or mastectomy plus sentinel lymph node biopsy with or without lymph node dissection
- Received radiotherapy with or without chemotherapy
- Diagnosed with breast cancer-related lymphedema at stage I or higher
- Age 18 years or older
- Able to follow the study protocol
- Able to provide written informed consent
You will not qualify if you...
- Metastatic disease
- Pregnancy
- History of surgery or trauma to the arm
- History of arm infection within the past 3 months
- Use of medications affecting body fluids (like diuretics) in the last 3 months
- Severe psychological disorder or dementia
- Any unstable condition that may affect patient safety or study compliance as determined by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hasselt University
Hasselt, Limburg, Belgium, 3500
Actively Recruiting
2
Jessa Ziekenhuis
Hasselt, Limburg, Belgium, 3500
Actively Recruiting
Research Team
J
Jolien Robijns, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here